Displaying drugs 2001 - 2025 of 2797 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Vismodegib | 421.297 C19H14Cl2N2O3S | A hedgehog pathway inhibitor used to treat patients with locally advanced or metastatic basal cell carcinoma. | Hedgehog pathway inhibitors | |
Bendroflumethiazide | 421.415 C15H14F3N3O4S2 | A diuretic used to suppress lactation and to treat hypertension and edema. | Low-Ceiling Diuretics and Potassium-Sparing Agents / Sulfonamides | |
Topotecan | 421.4458 C23H23N3O5 | An antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer. | Topoisomerase 1 (TOP1) inhibitors | |
Pitavastatin | 421.4608 C25H24FNO4 | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. | Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypolipidemic Agents Indicated for Hyperlipidemia | |
Givinostat | 421.497 C24H27N3O4 | A histone deacetylase inhibitor indicated for the treatment of Duchenne Muscular Dystrophy (DMD). | Enzyme Inhibitors | |
Kappadione | 422.084 C11H8Na4O8P2 | Anticoagulant-induced prothrombin deficiency caused by coumadin or indanedione derivatives, prophylaxis and therapy of hemorrhagic disease of the newborn, hypoprothrombinemia due to antibacterial therapy, hypoprothrombinemia secondary to factors limiting absorption or... | Not Available | |
Indigotindisulfonic acid | 422.389 C16H10N2O8S2 | A medication used to visualize ureteral orifices during cystoscopy and ureteral catheterization. | Tests for Renal Function and Ureteral Injuries | |
Riociguat | 422.4157 C20H19FN8O2 | A stimulator of soluble guanylate cyclase indicated for the management of persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. | Antihypertensives for Pulmonary Arterial Hypertension | |
Iptacopan | 422.525 C25H30N2O4 | A factor B inhibitor used to treat paroxysmal nocturnal hemoglobinuria. | Complement Inactivating Agents | |
Docusate | 422.577 C20H38O7S | A medication used to treat constipation associated with dry, hard stools, or opioid induced constipation. | Enemas / Softeners, Emollients | |
Losartan | 422.911 C22H23ClN6O | An angiotensin receptor blocker used to treat hypertension and diabetic nephropathy, and is used to reduce the risk of stroke. | Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics | |
Chloramphenicol succinate | 423.202 C15H16Cl2N2O8 | A broad-spectrum antibiotic agent used for the treatment of acute and severe infections caused by susceptible bacterial strains. | Anti-Bacterial Agents | |
Cefapirin | 423.463 C17H17N3O6S2 | A first generation cephalosporin indicated in the treatment of susceptible bacterial infections. | Anti-Bacterial Agents / First-Generation Cephalosporins | |
Cocarboxylase | 424.306 C12H18N4O7P2S | The coenzyme form of Vitamin B1 present in many animal tissues. It is a required intermediate in the pyruvate dehydrogenase complex and the ketoglutarate dehydrogenase complex. | Coenzymes / Vitamin B Complex | |
Cefuroxime | 424.385 C16H16N4O8S | A cephalosporin indicated for the treatment of a variety of infections including acute bacterial otitis media, several upper respiratory tract infections, skin infections, urinary tract infections, gonorrhea, early Lyme disease, and impetigo. | Anti-Bacterial Agents / Cephalosporins / Second-Generation Cephalosporins | |
Benazepril | 424.4895 C24H28N2O5 | An ACE inhibitor prodrug used to treat hypertension. | ACE Inhibitors and Calcium Channel Blockers / ACE Inhibitors and Diuretics | |
Eprosartan | 424.513 C23H24N2O4S | An ARB used to treat hypertension, diabetic nephropathy, and congestive heart failure. | Angiotensin II receptor blockers (ARBs) and diuretics | |
Pravastatin | 424.5277 C23H36O7 | An HMG-CoA reductase inhibitor used to lower lipid levels and to reduce the risk of cardiovascular events, including myocardial infarction and stroke. | Anticholesteremic Agents / Drugs causing inadvertant photosensitivity / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Hypolipidemic Agents Indicated for Hyperlipidemia | |
Alvimopan | 424.5326 C25H32N2O4 | An opioid antagonist used to reduce healing time of the upper and lower gastrointestinal tract following surgical procedures that involve bowel resection with primary anastomosis. | Peripheral Opioid Receptor Antagonists | |
Difenoxin | 424.5341 C28H28N2O2 | An antidiarrheal agent used as an adjunct for the management of acute nonspecific diarrhea and acute exacerbations of chronic functional diarrhea. | Antipropulsives | |
Sotagliflozin | 424.94 C21H25ClO5S | An orally administered dual SGLT1/2 inhibitor used alongside insulin to improve glycemic control in patients with type 1 diabetes mellitus. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 1, antagonists & inhibitors / Sodium-Glucose Transporter 2 Inhibitors | |
Clindamycin | 424.98 C18H33ClN2O5S | A lincosamide antibiotic used to treat serious infections caused by susceptible anaerobic, streptococcal, staphylococcal, and pneumococcal bacteria. | Antiinfectives for Treatment of Acne / Lincosamides | |
Deucravacitinib | 425.467 C20H22N8O3 | A TYK2 inhibitor being investigated as a treatment for psoriasis. | Selective Immunosuppressants | |
Filgotinib | 425.51 C21H23N5O3S | A Janus kinase (JAK) 1 selective inhibitor used to treat cases of rheumatoid arthritis that are unresponsive to conventional treatments. | Janus Kinase Inhibitor / Selective Immunosuppressants | |
Doravirine | 425.749 C17H11ClF3N5O3 | A non-nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals to treat HIV-1 infections. | Non-Nucleoside Reverse Transcriptase Inhibitors |
Displaying drugs 2001 - 2025 of 2797 in total